Balasa Dinverno & Foltz’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $665K | Sell |
3,175
-32
| -1% | -$6.7K | 0.04% | 171 |
|
|
2022
Q2 | $756K | Sell |
3,207
-442
| -12% | -$104K | 0.05% | 152 |
|
|
2022
Q1 | $655K | Sell |
3,649
-541
| -13% | -$97.1K | 0.04% | 171 |
|
|
2021
Q4 | $905K | Sell |
4,190
-58
| -1% | -$12.5K | 0.06% | 139 |
|
|
2021
Q3 | $784K | Sell |
4,248
-301
| -7% | -$55.6K | 0.05% | 140 |
|
|
2021
Q2 | $816K | Sell |
4,549
-590
| -11% | -$106K | 0.06% | 135 |
|
|
2021
Q1 | $860K | Buy |
5,139
+1,618
| +46% | +$271K | 0.07% | 128 |
|
|
2020
Q4 | $534K | Sell |
3,521
-3,206
| -48% | -$486K | 0.04% | 163 |
|
|
2020
Q3 | $679K | Buy |
6,727
+1,353
| +25% | +$137K | 0.06% | 128 |
|
|
2020
Q2 | $650K | Buy |
+5,374
| New | +$650K | 0.07% | 116 |
|
|
2018
Q4 | – | Sell |
-2,034
| Closed | -$260K | – | 248 |
|
|
2018
Q3 | $260K | Buy |
+2,034
| New | +$260K | 0.03% | 204 |
|
|
2017
Q2 | – | Sell |
-2,559
| Closed | -$346K | – | 213 |
|
|
2017
Q1 | $346K | Buy |
+2,559
| New | +$346K | 0.06% | 141 |
|